1) Sheth S., Bedford A., Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. American Journal of Gastroenterology. 2000.-№95.- С.1402-1410.
2) Hueman M.T., Vollmer C.M., Pawlik T.M. Evolving treatment strategies for gallbladder cancer. Annals of Surgical Oncology. -2009.- №16.-С.2101-2115.
3) Hundal R., Shaffer E.A. Gallbladder cancer: epidemiology and outcome. ClinicalEpi-demiology.- 2014.-№6.-С.99-109.
4) Patel T. Cholangiocarcinoma - controversies and challenges. Nature Reviews Gastroenterology Hepatology. 2011.- №8.-С.189-200.
5) Yamamoto S., Kubo S., Hai S., et al. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Science. 2004.-№95.- C.592-595.
6) Welzel T.M., Graubard B.I., El-Serag H.B., et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clinical Gastroenterology Hepatology. 2007. - №5. - С.1221-1228.
7) Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. Злокачественные новообразования в России в 2014 году (заболеваемость и смертность) - М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИРЦ» Минздрава России, -2016. -илл. -250 с.
8) Zhu A.X., Hong T.S., Hezel A.F., Kooby D.A. Current management of gallbladder carcinoma. Oncologist. 2010.- №15.-С.168-181.
9) Valle1 J. W., Borbath I., Khan S. A., et al. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 27 (Supplement 5): v28-v37, 2016 doi:10.1093/annonc/mdw324.
10) DeOliveira M.L., Cunningham S.C., Cameron J.L., et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Annals of Surgery. 2007.-№245. -С.755-762.
11) Lim J.H. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. American Journal ofRoentgenology. 2003.-№181. -С.819-827.
12) Hawkins W.G., DeMatteo R.P., Jarnagin W.R., et al. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Annals of Surgical Oncology. 2004. -№11. -С.310-315.
13) Jarnagin W.R., Ruo L., Little S.A., et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003. - №98. -С.1689-1700.
14) Furlan A., Ferris J.V., Hosseinzadeh K., Borhani A.A. Gallbladder carcinoma update: multimodality imaging evaluation, staging, and treatment options. American Journal of Roentgenology. -2008.-№191. - C.1440-1447.
15) Miller G., Schwartz L.H., D'Angelica M. The use of imaging in the diagnosis and staging of hepatobiliary malignancies. Surgical Oncology Clinics of North America. 2007. -№16. -С.343-368.
16) Levy A.D., Murakata L.A., Rohrmann C.A., Jr. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics. 2001. -№21. -С.295-314.
17) Petrowsky H., Wildbrett P., Husarik D.B., et al.Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. Journal of Hepatology. 2006. -№45(1). -С.43-50.
18) Khan Z.S., Livingston E.H., Huerta S. Reassessing the need for prophylactic surgery in patients with porcelain gallbladder: case series and systematic review of the literature. Archives of Surgery. 2011.- №146. -С.1143-1147.
19) Eckel F., Brunner T. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Jelic Annals of Oncology 22 (Supplement 6): vi40-vi44, 2011 clinical practice guidelines. doi:10.1093/annonc/mdr375
20) Zografos G., Farfaras A., Zagouri F., et al. Cholangiocarcinoma: principles and current trends. Hepatobiliary Pancreatic Diseases International. 2011. - 10 (1). - C.10-20.
21) Nagino M., Kamiya J., Nishio H., et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Annals of Surgery. 2006. -№243. -С.364-372.
22) Regimbeau J.M., Fuks D., Le Treut Y-P.,et al. Surgery for Hilar Cholangiocarcino-ma: A Multi-institutional Update on Practice and Outcome by the AFC-HC Study Group. Journal of Gastrointestinal Surgery. 2011. -№15.-С.480-488.
23) Coburn N.G., Cleary S.P., Tan J.C., Law C.H. Surgery for gallbladder cancer: a population-based analysis. Journal of the American College of Surgeons. 2008. -№207. -С.371382.
24) Downing Sr CKOG, et al. Early-stage gallbladder cancer in the surveillance, epidemiology, and end results database: Effect of extended surgical resection. Archives of Surgery. 2011. -№146. -С.734-738.
25) Goetze T.O., Paolucci V. Benefits of reoperation of T2 and more advanced incidental gallbladder carcinoma: analysis of the German registry. Annals of Surgery. 2008. -№247. -С.104-108.
26) Murakami Y., Uemura K., SudoT.,et al. Prognostic Factors After Surgical Resection for Intrahepatic, Hilar, and Distal Cholangiocarcinoma. Annals of Surgical Oncology. 2011. -№18. -С.651-658
27) Meyer C.G., Penn I., James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation. - 2000. -№69. -С.1633-1637.
28) Zografos G., Farfaras A., Zagouri F., et al. Cholangiocarcinoma: principles and current trends. Hepatobiliary Pancreatic Diseases International. 2011. -№10 (1). -С.10-20.
29) Neuhaus P., Jonas S., Settmacher U., et al. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbeck’s Archives of Surgery. 2003. - №388. -С.194-200.
30) Nagino M., Kamiya J., Arai T., et al. “Anatomic” right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma. AnnalsofSur-gery. 2006. - №243. - С.28-32.
31) Бредер В.В., Косырев В.Ю., Ледин Е.В. Практические рекомендации по лекарственному лечению билиарного рака. RUSSCO. Версия 2017.